Content about Pulmonology

November 28, 2012

The November/December 2012 Cough, Cold and Flu Ingredient Guide breaks down the indication, ingredients, purpose and dosage of Mucinex, Vicks, Advil, Theraflu, Delsym, St. Joseph, Hyland's Similasan and Zicam products.

The November/December 2012 Cough, Cold and Flu Ingredient Guide breaks down the indication, ingredients, purpose and dosage of Mucinex, Vicks, Advil, Theraflu, Delsym, St. Joseph, Hyland's Similasan and Zicam products.

Click here for the complete guide.

September 27, 2012

Dr. Reddy's Labs has launched a generic drug for treating asthma and allergies, and preventing bronchospasm during exercise, the company said.

HYDERABAD, India — Dr. Reddy's Labs has launched a generic drug for treating asthma and allergies, and preventing bronchospasm during exercise, the company said.

The Indian company announced the launch of montelukast sodium oral granules in the 4-mg strength in unit-dose cartons of 30 packets.

The drug is a version of Merck's Singulair oral granules, which had sales of about $61 million during the 12-month period ended in July, according to IMS Health.

September 20, 2012

The Food and Drug Administration has approved a drug made by Acton Pharmaceuticals for asthma, the company said Thursday.

MARLBOROUGH, Mass. – The Food and Drug Administration has approved a drug made by Acton Pharmaceuticals for asthma, the company said Thursday.

The drug maker announced the approval of Aerospan (flunisolide HFA) inhalation aerosol as a maintenance treatment for asthma in patients aged 6 and older. The drug maker plans to launch the drug in early 2013.

September 18, 2012

Boehringer Ingelheim Pharmaceuticals has launched a drug for treating chronic obstructive pulmonary disease, the company said Tuesday.

RIDGEFIELD, Conn. — Boehringer Ingelheim Pharmaceuticals has launched a drug for treating chronic obstructive pulmonary disease, the company said Tuesday.

BI Pharmaceuticals announced the launch of Combivent Respimat (ipratropium bromide and albuterol), calling it a propellant-free inhaler that uses a slow-moving mist to deliver the same active ingredients as the Combivent metered dose inhaler, requiring one inhalation per dose, compared with Combivent MDI's two inhalations.

September 18, 2012

Earlier this summer Hyland’s introduced its Leg Cramps Ointment to complement its line of homeopathic Leg Cramps tablets. Expect the leg cramp market to grow.

LOS ANGELES — Earlier this summer Hyland’s introduced its Leg Cramps Ointment to complement its line of homeopathic Leg Cramps tablets. Expect the leg cramp market to grow. According to one study, about half of all seniors suffer from leg cramps — they’re more common in women (56%) than men (40%). And two drug classes with strong links to leg cramps include diuretics and the inhaled long-acting B2-agonists 
(e.g., Advair, Serevent, Symbicort).

September 4, 2012

Zarbee's has boosted its portfolio of all-natural cough products to include an extra-strength line.

SALT LAKE CITY — Zarbee's has boosted its portfolio of all-natural cough products to include an extra-strength line.

Designed for those ages 12 years and older, the over-the-counter extra-strength all-natural cough products will supplement the existing line of Zarbee's original cough products, which currently are available for children ages 12 months and older. The new extra-strength products are specially formulated at a higher strength and dose than the original children's product, Zarbee's said.

August 16, 2012

According to the American College of Allergy, Asthma and Immunology, 25 million adults and children across the country were diagnosed with rhinitis, or hay fever, within the last 12 months, which may lead many to believe they’ve caught an early-season cold.

ARLINGTON HEIGHTS, Ill. — According to the American College of Allergy, Asthma and Immunology, 25 million adults and children across the country were diagnosed with rhinitis, or hay fever, within the last 12 months, which may lead many to believe they’ve caught an early-season cold.

August 16, 2012

Pharmaca Integrative Pharmacy on Tuesday announced that it now is offering immunizations for influenza, whooping cough, pneumonia and shingles on a walk-in basis at all of its locations.

BOULDER, Colo. — Pharmaca Integrative Pharmacy on Tuesday announced that it now is offering immunizations for influenza, whooping cough, pneumonia and shingles on a walk-in basis at all of its locations. Pharmaca pharmacists can provide the shots to any customer who requests one during open pharmacy hours.
 

August 14, 2012

Drug maker Mylan will pass out free EpiPen injectors to children in schools, the company said Tuesday.

BASKING RIDGE, N.J. — Drug maker Mylan will pass out free EpiPen injectors to children in schools, the company said Tuesday.

Mylan Specialty, the Mylan unit that makes the EpiPen (epinephrine), announced the launch of the EpiPen4Schools program. The program offers four free EpiPen or EpiPen Jr. injectors to public and private school students in kindergarten, elementary, middle and high school, who have valid prescriptions.

August 13, 2012

The Food and Drug Administration has approved a voice-guided injection device made by Sanofi for severe allergic reactions, the drug maker said Monday.

PARIS — The Food and Drug Administration has approved a voice-guided injection device made by Sanofi for severe allergic reactions, the drug maker said Monday.

The French drug maker announced the approval of Auvi-Q (epinephrine), calling it the first epinephrine auto-injector with audio and visual cues that guides users through the injection process. Sanofi US licensed the North American commercialization rights to Auvi-Q from Intelliject, which has retained commercialization rights for the rest of the world.

August 9, 2012

Four-out-of-5 seasonal allergy sufferers reported their fitness regimens suffer because they exercise less or their performance isn't as strong, according to a survey released Thursday from AllergEase.

ARLINGTON, Va. — Four-out-of-5 seasonal allergy sufferers reported their fitness regimens suffer because they exercise less or their performance isn't as strong, according to a survey released Thursday from AllergEase.

The survey also captured some of the social implications of being a seasonal allergy sufferer. Nearly 45% of people have turned down social invitations because of their seasonal allergies, the survey found, and 40% reported having had a vacation or getaway negatively affected by seasonal allergies.

August 6, 2012

The Food and Drug Administration has approved several generic versions of a drug used to treat asthma and allergies, the agency said Friday.

SILVER SPRING, Md. — The Food and Drug Administration has approved several generic versions of a drug used to treat asthma and allergies, the agency said Friday.

The FDA announced the approval of montelukast sodium, a drug indicated for controlling asthma symptoms and relieving indoor and outdoor allergies.

The drug is a generic version of Merck's Singulair, which had sales of $4.6 billion in 2011, according to IMS Health.

June 21, 2012

Retailers are awakening to the possibility that their sleep aids — typically merchandised near the floor level of a set synergistically near tablet pain relievers — may deserve a placement closer to eye level.

Retailers are awakening to the possibility that their sleep aids — typically merchandised near the floor level of a set synergistically near tablet pain relievers — may deserve a placement closer to eye level. It may sound cliché to characterize sleep aids as a sleeper category — that is until you look at the 11.6% trailing 52-week dollar growth, and then back down to the floor where the sleep aids are typically merchandised.


June 12, 2012

The 2011-2012 influenza season was one of the mildest and latest seasons on record, according to a report from the Centers for Disease Control and Prevention.

ATLANTA — The 2011-2012 influenza season was one of the mildest and latest seasons on record, according to a report from the Centers for Disease Control and Prevention.

The peak percentage of outpatient visits for influenza-like illnesses of 2.4% was the lowest reported since the system began in its current format in 1997. The peak percentage of visits for ILI during those 14 seasons ranged from 3.2% for the 2002-2003 season to 7.7% during the 2009 H1N1 pandemic.

May 29, 2012

CVS/pharmacy has announced the launch of a new in-store fundraising campaign, named Advancing Medical Research, to support medical research and help improve the quality of life for those living with amyotrophic lateral sclerosis and cystic fibrosis.

WOONSOCKET, R.I. — CVS/pharmacy has announced the launch of a new in-store fundraising campaign, named Advancing Medical Research, to support medical research and help improve the quality of life for those living with amyotrophic lateral sclerosis and cystic fibrosis.
 
Funds raised through the campaign will benefit the ALS Therapy Alliance, an organization dedicated to advancing ALS research, and the Cystic Fibrosis Foundation. Supporters for the 2012 campaign can donate $1 or $3 at the register in CVS/pharmacy locations and online through June 30.

May 23, 2012

Taken together, asthma and chronic obstructive pulmonary disease — which includes chronic bronchitis and emphysema — affect nearly 50 million Americans, or about 15% of the total U.S. population, according to statistics from such organizations as the Centers for Disease Control and Prevention. And combined, the two diseases cause more than 100,000 deaths per year. Fortunately, however, there is a wide range of treatments available for both, many of which work for both diseases.

Taken together, asthma and chronic obstructive pulmonary disease — which includes chronic bronchitis and emphysema — affect nearly 50 million Americans, or about 15% of the total U.S. population, according to statistics from such organizations as the Centers for Disease Control and Prevention. And combined, the two diseases cause more than 100,000 deaths per year. Fortunately, however, there is a wide range of treatments available for both, many of which work for both diseases.

May 16, 2012

In contrast to the most recent cough-cold season, which was characterized by a relative lack of upper respiratory illnesses, pharmacy shoppers with itchy eyes, runny noses and audible sneezes have been back in force this spring in search of allergy relief.

In contrast to the most recent cough-cold season, which was characterized by a relative lack of upper respiratory illnesses, pharmacy shoppers with itchy eyes, runny noses and audible sneezes have been back in force this spring in search of allergy relief. And those patients are gravitating toward the OTC aisle for their seasonal allergy needs now that the last of the second-generation antihistamines was made available without a prescription a year ago. 


May 16, 2012

Optics Laboratory recently kicked off a new consumer campaign in support of its OcuFresh Eye Wash product. The product, which helps flush eye irritants like pollen, dust and smoke without perservatives, will be featured across the “Mommy Blog” circuit.


Optics Laboratory recently kicked off a new consumer campaign in support of its OcuFresh Eye Wash product. The product, which helps flush eye irritants like pollen, dust and smoke without perservatives, will be featured across the “Mommy Blog” circuit.


April 16, 2012

Children under the age of 10 years old may be especially susceptible to a new strain of influenza, according to an article published Friday in the Center for Disease Control and Prevention's "Morbidity and Mortality Weekly Report."

ATLANTA — Children under the age of 10 years old may be especially susceptible to a new strain of influenza, according to an article published Friday in the Center for Disease Control and Prevention's "Morbidity and Mortality Weekly Report."

April 6, 2012

McNeil Consumer Healthcare, the maker of Zyrtec, on Wednesday announced that actress Kate Walsh and beauty expert Rebekah George will address "allergy face" — the beauty challenges that can come along with typical allergy symptoms — during a live webcast April 10 at 8 p.m. EST on Ustream, a live interactive broadcast platform.

FORT WASHINGTON, Pa. — McNeil Consumer Healthcare, the maker of Zyrtec, on Wednesday announced that actress Kate Walsh and beauty expert Rebekah George will address "allergy face" — the beauty challenges that can come along with typical allergy symptoms — during a live webcast April 10 at 8 p.m. EST on Ustream, a live interactive broadcast platform.

March 28, 2012

A mild winter may be setting the stage for a particularly strong spring allergy season for sufferers allergic to tree pollens and mold. The incidence of seasonal allergy has been soft of late, but IMS Health is predicting a significant uptick in allergy sufferers in the coming months.

A mild winter may be setting the stage for a particularly strong spring allergy season for sufferers allergic to tree pollens and mold. The incidence of seasonal allergy has been soft of late, but IMS Health is predicting a significant uptick in allergy sufferers in the coming months.

March 26, 2012

The Food and Drug Administration has approved a drug made by Teva for treating allergies, the company said Monday.

JERUSALEM — The Food and Drug Administration has approved a drug made by Teva for treating allergies, the company said Monday.

Teva announced the approval of Qnasl (beclomethasone dipropionate) for seasonal and year-round nasal allergies in patients ages 12 years and older. The company said the drug, a "dry" nasal aerosol, would become available next month.

March 21, 2012

Optics Lab has kicked off a new consumer campaign in support of its OcuFresh Eye Wash product, the company announced Tuesday.

EL MONTE, Calif. — Optics Lab has kicked off a new consumer campaign in support of its OcuFresh Eye Wash product, the company announced Tuesday.

The product, which helps flush out such eye irritants as pollen, dust and smoke, will be featured across the "Mommy Blog" circuit and in such print publications as Prevention, Redbook and Allergies Today.

The company also is circulating a 15-second spot featured on YouTube here.

February 17, 2012

As of the beginning of February, the cough-cold season had yet to materialize and illness levels were only just beginning to climb. If that’s the case, then an expected illness peak in late February/early March would make the 2011-2012 cough, cold and flu season one of the later-peaking seasons in recent years.


As of the beginning of February, the cough-cold season had yet to materialize and illness levels were only just beginning to climb. If that’s the case, then an expected illness peak in late February/early March would make the 2011-2012 cough, cold and flu season one of the later-peaking seasons in recent years.


As of Jan. 21, overall incidence of upper respiratory illness this season was down 7.5% according to IMS Health, as compared with the 2010-2011 season.


February 17, 2012

As of early February, incidence of cough-cold and influenza still was relatively low, but the season has yet to peak and that means there could be demand for symptomatic relief through March.


As of early February, incidence of cough-cold and influenza still was relatively low, but the season has yet to peak and that means there could be demand for symptomatic relief through March.


“Fever is just starting to move,” noted Scott Hanslip, director of sales for IMS Consumer Health, in the first week of February. However, overall incidence of upper respiratory illness was down 7.5% from September through Jan. 21, 
according to IMS Health tracking.